BGI
ETNB

B Group Inc’s 89bio ETNB Stock Holding History

B Group Inc’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-95,623
Closed -$695K – 20
2025
Q1 		$695K Buy
+95,623
New +$836K 0.6% 17

Other funds holding ETNB

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

B Group Inc's ETNB Position: Q2 2025 in Review

B Group Inc sold out of 89bio (ETNB) in Q2 2025, closing a stake of 95,623 shares — an estimated $695K sold.

B Group Inc first reported a position in ETNB in Q1 2025 and held it in 1 quarter. The position peaked at $695K in Q1 2025. 184 funds tracked by Wall St. Rank hold ETNB as of Q2 2025.

  • B Group Inc reported no remaining 89bio position as of Q2 2025 after selling out during the quarter.
  • B Group Inc sold 95,623 89bio shares in Q2 2025, an estimated $695K.
  • B Group Inc first reported a position in 89bio in Q1 2025 and held it in 1 quarter.
  • B Group Inc's 89bio position peaked at $695K in Q1 2025.
  • 184 funds tracked by Wall St. Rank held 89bio as of Q2 2025.

Based on B Group Inc's 13F filing for Q2 2025, filed 14 Aug 2025.